Bellevue Group AG grew its holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,535,839 shares of the company’s stock after buying an additional 400,000 shares during the quarter. Bellevue […]
Wedbush Increases Black Diamond Therapeutics (NASDAQ:BDTX) Price Target to $16 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Deerfield Management Company L.P. Series C lessened its stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 930,447 shares of the company’s stock after selling 869,553 shares during […]
Deerfield Management Company L.P. Series C lessened its holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 48.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 930,447 shares of the company’s stock after selling 869,553 shares during the period. Deerfield Management […]
Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 80.6% of Beam […]